Last updated: August 28, 2025
Introduction
Patent KR20170048511, granted in South Korea, pertains to a pharmaceutical invention designed to improve therapeutic efficacy or stability of a specific drug compound or formulation. As part of a comprehensive patent landscape analysis, understanding its scope, claims, and broader patent environment is essential for pharmaceutical innovators, researchers, and legal strategists aiming to navigate the competitive landscape within South Korea.
Scope of Patent KR20170048511
The scope of KR20170048511 centers on the novel aspects of a specific drug formulation or compound, detailing its unique chemical structure, method of preparation, or administration method. Typically, such patents aim to protect inventive features that distinguish the drug from existing therapies, which may include:
-
Chemical structure modifications: Incorporating specific substituents or stereochemistry that enhance activity or stability.
-
Formulation innovations: Novel delivery systems such as controlled-release matrices, stabilized suspensions, or co-crystals.
-
Method of manufacturing: Unique synthesis pathways, purification processes, or encapsulation techniques.
-
Therapeutic application: Specific indications or improved pharmacokinetic profiles.
For KR20170048511, the scope likely encompasses claims that cover a specific chemical entity, its preparation method, and its use in treating particular medical conditions. The patent aims to secure rights that prevent others from manufacturing, using, or selling a substantially similar formulation within South Korea for the duration of the patent term.
Claims Analysis
The claims define the legal boundaries of the patent’s protection. They are generally divided into independent and dependent claims:
1. Independent Claims
Dependent claims refer back to independent claims and specify particular embodiments or features. The core of KR20170048511 likely contains an independent claim that covers the primary inventive element, such as:
- Chemical Compound Claim: A compound with a specific structure (e.g., a novel chemotherapeutic agent or a biologic molecule with particular modifications).
- Method of Synthesis: A detailed process for manufacturing the compound or formulation.
- Use Claims: Specific therapeutic applications, such as treatment of a certain disease (e.g., cancer, autoimmune disorders).
Example (Hypothetical):
"A compound represented by Chemical Formula I, wherein R1 and R2 are defined groups, capable of inhibiting [target enzyme], and its use in the treatment of [medical condition]."
This claim protects the specific chemical invention and its therapeutic application.
2. Dependent Claims
Dependent claims add further specificity, such as:
- Variations in substituents.
- Alternative methods of synthesis.
- Specific formulations (e.g., dosage forms, excipients).
- Particular dosages or administration routes.
Implication: The claims' breadth impacts patent strength: broad claims cover a wide scope but may face greater validity challenges, while narrower claims provide more precise protection.
3. Claim Strategy and Limitations
KR20170048511 overall emphasizes protecting the core compound/method, with claims tailored to balance novelty, inventive step, and industrial applicability, adhering to South Korea’s patent standards. The claims likely avoid overly broad language that could be invalidated and instead focus on inventive features that set the drug apart from prior art.
Patent Landscape in South Korea and Global Context
1. South Korean Patent Environment
South Korea’s patent system, governed by the Korean Intellectual Property Office (KIPO), is renowned for its rigorous examination standards, emphasizing inventiveness and novelty. The pharma patent landscape is highly active, driven by domestic companies such as Samsung Bioepis, Celltrion, and LG Chem, and international players seeking protection in the Asian markets.
- Precedent for pharma patents: The country’s patent office closely examines chemical novelty, inventive step, and industrial applicability, often resulting in narrow claims that protect specific compounds or formulations.
- Patent term and life cycle: Pharmaceuticals benefit from 20 years from filing, but data exclusivity and patent term extensions (through pediatric or supplementary protection certificates) can extend market exclusivity.
2. Patent Family and Related Patents
Most pharmaceutical patents are filed as part of a broader patent family, including filings in China, Japan, US, and Europe to ensure global coverage. KR20170048511 might be associated with:
- A family of patents covering the compound, formulation, and methods.
- Patent applications in other jurisdictions claiming similar subject matter.
3. Competitive Patent Players
The Korean patent landscape for drugs covering KR20170048511 likely overlaps with patents from major pharmaceutical firms and biotech companies. These players pursue patent protection on:
- Similar chemical scaffolds.
- Alternative formulations.
- Methods of use for related indications.
Understanding these related patents is vital for freedom-to-operate assessments and delineating potential infringement risks.
Legal and Strategic Implications
The scope defined by the claims determines potential infringement or nullification risks. Narrow claims increase validity but limit exclusivity, while broad claims enhance market control but face greater validity challenges against prior art. Additionally, patent term strategies—such as supplementary protection certificates—can extend exclusivity beyond the standard 20-year term.
Pharmaceutical companies must align patent positioning with research and development pipelines and consider licensing or patent opposition opportunities within South Korea’s vibrant IP environment.
Conclusion
KR20170048511 exemplifies a targeted pharmaceutical patent designed to carve out proprietary rights over a novel drug compound, formulation, or method. Its scope and claims aim to provide strong, enforceable protection within South Korea, balancing novelty and inventive step. The patent landscape surrounding such drugs is competitive, with a dense network of patents across jurisdictions, underscoring the importance of thorough patent landscaping and strategic patent management.
Key Takeaways
- Claim Focus: Strong, specific claims proportionate to the inventive contribution maximize enforceability and patent validity.
- Patent Strategy: Broader claims can boost market exclusivity but risk invalidation; narrower claims reduce this risk but limit scope.
- Global Positioning: South Korea’s patent environment prioritizes strict examination; filing internationally enhances protection.
- Landscape Vigilance: Monitoring patent equivalents and related applications is critical for freedom-to-operate assessments.
- Lifecycle Management: Complementary protections like patent term extensions can sustain market exclusivity.
FAQs
1. What are the typical elements protected by pharmaceutical patents like KR20170048511?
Pharmaceutical patents generally protect chemical compounds, formulations, synthesis methods, and therapeutic uses, focusing on innovations that improve efficacy, stability, or delivery.
2. How does the scope of claims affect patent validity?
Broader claims offer wider protection but face a higher chance of invalidation due to prior art; narrower claims are more defensible but limit exclusivity.
3. Can similar patents threaten the enforceability of KR20170048511?
Yes; patents claiming similar compounds or methods in South Korea or abroad can create competitive or legal challenges, especially if they overlap or claim prior art.
4. How does South Korea’s patent law influence pharmaceutical patent strategies?
The law emphasizes inventive step and novelty, encouraging precise, defensible claims and strategic international filings to secure global exclusivity.
5. Why is patent landscaping important for pharmaceutical companies?
It identifies potential infringement risks, opportunities for licensing, and gaps in protection, guiding R&D and litigation strategies effectively.
Sources
- Korean Intellectual Property Office (KIPO). Patent Examination Guidelines for Pharmaceuticals.
- WIPO Patent Landscape Reports. South Korea Pharmaceutical Patent Environment.
- Patent KR20170048511 document.
- International Patent Classification (IPC) codes relevant to pharmaceuticals.
- Industry analyses on South Korea’s biotech and pharmaceutical IP strategies.
